AstraZeneca Inks R&D Deal With Ramaswamy's Roivant for Hush-Hush Indication Post author:Sam Post published:October 18, 2017 Post category:BioPharma Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra. Source: BioSpace You Might Also Like 4 Small-Cap Biotechs to Consider if Gilead Isn???t Doing it For You March 20, 2017 Medtronic Orders Employees to Evacuate California Facilities October 9, 2017 Arcturus CEO Ousted, Effective Immediately February 1, 2018
